IDEAYA Biosciences, Inc. IDYA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s accounts payable?
- IDEAYA Biosciences, Inc. (IDYA) reported accounts payable of $20.74M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s accounts payable changed year-over-year?
- IDEAYA Biosciences, Inc.'s accounts payable increased by 17.6% year-over-year, from $17.63M to $20.74M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s accounts payable has grown at a 79.1% compound annual growth rate (CAGR), from $953K to $17.58M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.